Pneumonia caused by methicillin-resistant Staphylococcus aureus.
about
Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemicLinezolid has unique immunomodulatory effects in post-influenza community acquired MRSA pneumoniaInfluenza-associated bacterial pneumonia; managing and controlling infection on two fronts.Novel pandemic influenza A (H1N1) and community-associated methicillin-resistant Staphylococcus aureus pneumonia.Influenza-associated bacterial pathogens in patients with 2009 influenza A (H1N1) infection: impact of community-associated methicillin-resistant Staphylococcus aureus in Queensland, Australia.Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils.Predictive Factors of Methicillin-Resistant Staphylococcus aureus Infection in Elderly Patients with Community-Onset Pneumonia.Telavancin for hospital-acquired pneumonia: clinical response and 28-day survivalLack of a major role of Staphylococcus aureus Panton-Valentine leukocidin in lower respiratory tract infection in nonhuman primates.Feeding, simvastatin, and linezolidComparison of methicillin-resistant Staphylococcus aureus community-acquired and healthcare-associated pneumoniaFactors contributing to epidemic MRSA clones replacement in a hospital setting.Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens.Prediction of methicillin-resistant Staphylococcus aureus in patients with non-nosocomial pneumonia.Epidemiology and outcome of pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA) in Canadian hospitalsNosocomial and ventilator-associated pneumonia in a community hospital intensive care unit: a retrospective review and analysis.Defining severe pneumonia.Applications of the phytomedicine Echinacea purpurea (Purple Coneflower) in infectious diseases.Epidemiology of methicillin-resistant Staphylococcus aureus pneumonia in community hospitals.An evaluation of the emerging vaccines and immunotherapy against staphylococcal pneumonia in children.Predictors of Clinical Success in the Treatment of Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Nosocomial Pneumonia (NP).Intestinal Microbiota of Mice Influences Resistance to Staphylococcus aureus Pneumonia.Application of a methicillin-resistant Staphylococcus aureus risk score for community-onset pneumonia patients and outcomes with initial treatmentNo Outbreak of Vancomycin and Linezolid Resistance in Staphylococcal Pneumonia over a 10-Year Period.Influenza-induced type I interferon enhances susceptibility to gram-negative and gram-positive bacterial pneumonia in micePharmacodynamic Profile of GSK2140944 against Methicillin-Resistant Staphylococcus aureus in a Murine Lung Infection ModelAntibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens.Clinical impact of methicillin-resistant staphylococcus aureus on bacterial pneumonia: cultivation and 16S ribosomal RNA gene analysis of bronchoalveolar lavage fluid.In vivo platelet activation in critically ill patients with primary 2009 influenza A(H1N1)Mild-stretch mechanical ventilation upregulates toll-like receptor 2 and sensitizes the lung to bacterial lipopeptideMechanical Ventilation Alters the Development of Staphylococcus aureus Pneumonia in RabbitEarly use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trialVitamin D's potential to reduce the risk of hospital-acquired infections.Extracorporeal membrane oxygenation and toilet bronchoscopy as a bridge to pneumonectomy in severe community-acquired methicillin-resistant Staphylococcus aureus pneumonia.Serum Lipoproteins Are Critical for Pulmonary Innate Defense against Staphylococcus aureus Quorum Sensing.Efficacy of ceftaroline fosamil in a staphylococcal murine pneumonia model.Patient-associated risk factors for acquisition of methicillin-resistant Staphylococcus aureus in a tertiary care hospitalCytotoxic Virulence Predicts Mortality in Nosocomial Pneumonia Due to Methicillin-Resistant Staphylococcus aureus.Curcumin protects mice from Staphylococcus aureus pneumonia by interfering with the self-assembly process of α-hemolysin.
P2860
Q24614464-CDD31433-FC44-4A59-A4E0-7E627CB3AEC7Q28543159-F1CB2B9D-B776-4028-B5A2-DBDD8E509E64Q30368552-5378F460-2088-49AE-AAB4-C42106650DE8Q30370676-A139E8B5-7575-4801-97C7-DC021A416C83Q30407950-5E9B3ABA-3E83-446D-981A-0D84F5C7760AQ33523802-E501CBF3-999E-44AF-93D0-FB8E837F7AECQ33567395-36E01C95-68BB-48D4-A69B-692C5B0C7175Q33622851-00EEB056-B2E4-469A-B1A2-9CDF062FD9C5Q33703737-78BA5BC7-A333-416F-BCFB-1C12A02B1EFFQ33738977-A0378F18-C993-4599-944C-0A8813F74A5FQ33822603-E6A77D94-EF44-4587-BBCB-FB4FC38A59BEQ34384801-F70BEDB9-F25E-45C7-B15E-8739305F13E1Q34478074-41C46862-60D6-4AD7-A867-700111C97865Q34699108-7722B3F0-63D6-4FD8-A49C-F948F4258A36Q34928386-E88162C3-DB13-4BF7-AAE0-0DA79A5AB213Q34999500-19091A68-EA0A-46C6-ACBE-1D112FD73C6DQ35146116-87130A1E-7F23-4B40-A5AA-C4F50198081FQ35184605-8E091195-D1F0-4987-B268-FBE002657893Q35494999-AE699FEA-8A17-4C1F-AE9C-583D4742416BQ35534273-C235D030-A17E-480F-99C1-865A6E8B4E23Q35618211-EBB45906-EE25-465B-9D83-AF0395A42896Q35702508-3EEB094F-1FB9-49D9-B2C9-1B854BE08AE3Q35717842-270E576C-A4B2-4283-890E-C6CEC0B87B4FQ35780916-90F914A5-B4E0-43B6-B0DC-14E594847C99Q35785093-AD4FDD8A-B1A7-4509-99F9-1B748C27DF98Q35859321-CF5F6686-9E99-4452-B3CE-CC0E0B4BE513Q35859914-0CF1B0B9-A6BE-4590-8885-79003ECE41F5Q35943844-58600F84-0369-419C-9E3B-1B4B7C54FC28Q35991296-2E7252C4-5FA6-485A-9A49-BA830A4C30EBQ36009103-92C1589B-7D00-40A4-99FC-22F7458A7828Q36070461-CFED6155-884B-4ABB-9AD9-043C672DACD6Q36071632-33D79A43-010A-4BF9-8944-866DB7261627Q36093598-CCDE975B-5E24-4749-A81E-3AD41AFC67FEQ36187615-A86C4D81-07CC-4AC8-8D82-8E328960AD0BQ36298265-95926EDE-092F-4419-B1E5-F4844C2376BCQ36387278-D3540313-6857-4173-BF32-5FD0F1D8E313Q36396172-D635A0CC-9DE1-4F23-BCA6-572018989EA5Q36557806-1A57E59C-0C93-4D21-ACF0-871A1EE7097BQ36812827-9F1C172F-8473-47A2-BAD8-E0B026401FDAQ37039923-4BEE642D-FA8F-4004-A2A4-EFCA1D83F3A9
P2860
Pneumonia caused by methicillin-resistant Staphylococcus aureus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pneumonia caused by methicillin-resistant Staphylococcus aureus.
@en
Pneumonia caused by methicillin-resistant Staphylococcus aureus.
@nl
type
label
Pneumonia caused by methicillin-resistant Staphylococcus aureus.
@en
Pneumonia caused by methicillin-resistant Staphylococcus aureus.
@nl
prefLabel
Pneumonia caused by methicillin-resistant Staphylococcus aureus.
@en
Pneumonia caused by methicillin-resistant Staphylococcus aureus.
@nl
P2860
P356
P1476
Pneumonia caused by methicillin-resistant Staphylococcus aureus.
@en
P2093
Dilip Nathwani
Ethan Rubinstein
P2860
P304
P356
10.1086/533594
P407
P478
46 Suppl 5
P577
2008-06-01T00:00:00Z